- Integration
- The exact FDA package describes DICOM CT input and DICOM or RTSTRUCT organ-at-risk output to a DICOM-compliant treatment-planning system; verify exact local compatibility.
FDA source Exact FDA submission Checked 2026-09-04
This is the interface boundary described in the exact FDA package; current local compatibility, routing, identity, and archive behavior still require acceptance testing.
- Deployment and data flow
- The exact FDA package describes a specialized server on a local network for the EFAI HN-Segmentation release; verify current topology, service responsibility, and site configuration locally.
FDA source Exact FDA submission Checked 2026-09-04
This is the release-level boundary described in the exact FDA package; current hosting, contracts, security, availability, and site configuration remain separate evidence.
- Security and privacy
- Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04
Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.
- Training and support
- Only qualified radiation oncologists, medical physicists, dosimetrists, and radiation therapists should operate or interpret the product. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
FDA source Exact FDA submission Checked 2026-09-04
- Monitoring and change control
- Monitor K220264 by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Initial head-and-neck organ-at-risk contours require professional review and editing; the labeled system is not a decision-making or lesion-detection system.
FDA source Exact FDA submission Checked 2026-09-04
Monitoring guidance is buyer-facing implementation guidance derived from the exact cleared scope; it is not a claim that the FDA package provides a live monitoring service.
Release and scope verification
Map installed model, build, options, population, anatomy, inputs, outputs, and enabled functions to K220264 before acceptance.
exact submission · checked 2026-09-04 Later product-family features are not evidence that this cleared release includes them.
Deployment boundary
The exact FDA package describes a specialized server on a local network for the EFAI HN-Segmentation release; verify current topology, service responsibility, and site configuration locally.
exact submission · checked 2026-09-04 FDA-described deployment boundaries do not establish current hosting contracts, security controls, uptime, or local qualification.
Interoperability acceptance
The exact FDA package describes DICOM CT input and DICOM or RTSTRUCT organ-at-risk output to a DICOM-compliant treatment-planning system; verify exact local compatibility.
exact submission · checked 2026-09-04 Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.
Clinical acceptance
Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Initial head-and-neck organ-at-risk contours require professional review and editing; the labeled system is not a decision-making or lesion-detection system.
exact submission · checked 2026-09-04 Define stop-use, escalation, rollback, and revalidation triggers before production use.
Economic evaluation
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.
product family · checked 2026-09-04 No exact-product price was found in the reviewed public material; productivity or value claims require local evidence.
Lifecycle monitoring
Monitor K220264 by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Initial head-and-neck organ-at-risk contours require professional review and editing; the labeled system is not a decision-making or lesion-detection system.
exact submission · checked 2026-09-04 Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes. radiotherapy planning or image-processing software limits remain submission-specific.